Results 141 to 150 of about 5,839 (199)

Anesthesia for the First Fully Robotic Simultaneous Living Donor Liver Transplant in Europe. [PDF]

Cureus
Pereira FA, Pissarra F, Poeira R, Rocha P, Canas M, Dias S, Cadilha S, Pinto Marques H.   +7 more
europepmc   +1 more source

Factors Influencing the Use of G-CSF in Drug-Induced Agranulocytosis. [PDF]

Hematol Rep
Andrès E, Terrade JE, Jannot X, Lorenzo-Villalba N.   +3 more
europepmc   +1 more source

Metamizole limits proliferation in chronic myeloid leukemia cells and triggers apoptosis via the bax/bcl-2/caspase-3 cascade. [PDF]

Med Oncol
Maytalman E, Nemutlu Samur D.
europepmc   +1 more source

Diagnostic Challenges in a Pediatric Case of Recurrent Blistering Skin Reactions: Ibuprofen-Induced Fixed Drug Exanthema versus Infection-Triggered Erythema Multiforme. [PDF]

Drug Healthc Patient Saf
Möhrle R, Toni I, Wagner N, Schliep S, Hoerning A, Neubert A.   +5 more
europepmc   +1 more source

Differential risk signals of cutaneous adverse drug reactions among β-lactam antibiotics: ceftriaxone shows increased signals for SJS/TEN in clinical and real-world cohorts. [PDF]

Front Med (Lausanne)
von Grundherr L, Faesser HA, Recke A, Ludwig RJ, Boch K, Curman P.   +5 more
europepmc   +1 more source

Adverse Events Following Vitreoretinal Surgeries Under Adequacy of Anesthesia with Combined Paracetamol/Metamizole-Additional Report. [PDF]

J Clin Med
Marczak K, Stasiowski MJ, Lyssek-Boroń A, Zmarzły N.   +3 more
europepmc   +1 more source

Integrated pain management in a child with arthritis in Cape Verde: a case report. [PDF]

Front Pediatr
Dos Reis Cabral Semedo DS, de Sousa Lobo S, Mendonça Soares de Carvalho NA, Barros Martins C, Moreno Barros E, Castro Cardoso D, Dos Reis Cabral DE.   +6 more
europepmc   +1 more source

Metamizole-associated neutropenia: Comparison of patients with neutropenia and metamizole-tolerant patients [PDF]

European Journal of Internal Medicine, 2019
Reports of metamizole-induced neutropenia have increased in Switzerland and Germany over the last decades, most likely reflecting increased use of metamizole. To date, there are no effective strategies to identify patients at increased risk of metamizole-induced neutropenia.
Stephan Krähenbühl, Nicolas Bonadies, Evangelia Liakoni   +2 more
exaly   +7 more sources

Safety of metamizole: a systematic review of the literature

Journal of Clinical Pharmacy and Therapeutics, 2016
Metamizole was withdrawn from the market in the United States and several European countries following reports of fatal agranulocytosis among users, but is still available in many countries in Europe, South America and Asia. Over the past several decades, a number of epidemiologic studies have been conducted to quantify the risk of agranulocytosis and ...
Andrade, Susan E., Bartels, D. B., Lange, R., Sandford, L., Gurwitz, Jerry H.   +4 more
exaly   +5 more sources